triValence Unites Healthtech and Fintech

Looking to modernize how health care constituents pay and supply one another, industry veteran Dunston Almeida has launched a new company with a “nine-figure” commitment from New Enterprise Associates.

What’s happening

The new company, triValence, is building next-gen infrastructure to automate B2B supply-chain management and payment processes, Almeida tells Sarah.

  • In addition to Almeida, a former Zelis, eviCore and Medco executive, triValence has assembled executives with past experience at CVS, Inovalon, John Hopkins, Optum and Symplr.
  • Strategic advisers include former GE and Athenahealth CEO Jeff Immelt and ex-White House policy director Kavita Patel. Almeida says triValence aims for a 50% female leadership team.
Illustration: Annelise Capossela/Axios

Why it matters: The health care payments and supply chain ecosystem is inefficient and ripe for change. Providers manage vendors and systems that are siloed, and processes remain largely paper-based and manual.

  • Most health care payments innovation has focused on the consumer, whereas the B2B universe — despite its size — has lagged.
  • “There’s big demand because nobody is doing it,” Almeida says. “It’s boring. Not sexy. It’s infrastructure. It’s hard to do.”

Read the rest of this article at

Interested in learning

Subscribe today to stay informed and get regular updates from triValence.

Related Posts